A paper published Thursday in Clinical Infectious Diseases examines how barriers to appropriate diagnostic tools led to missed opportunities to curb antibiotic resistance and recommends steps to develop and expand the use of tests that can identify resistant bacteria.
Barbara D. Alexander, M.D., MHS, FIDSA – President, Infectious Diseases Society of America on today’s Pfizer/BioNTech application for Emergency Use Authorization of its COVID-19 vaccine candidate
With numbers of infections, illnesses, hospitalizations and deaths caused by COVID-19 at record highs as this holiday season begins, the risks posed by the spread of the coronavirus are more dangerous than at any time since its emergence last December.
Cornelius J. Clancy, M.D., member of the Infectious Diseases Society of America’s Antimicrobial Resistance Committee, presented on behalf of IDSA at today’s Food and Drug Administration public meeting to provide feedback on an FDA concept paper regarding the ranking of antimicrobial drugs according to their importance
电脑软件,破解软件,授权补丁,注册机-拿去吧论坛:热门电脑软件,PC软件破解,授权破解,注册机, 破解补丁下载。 Win软件 14 Mac软件 3 回复 最新 精华 Win软件 三款cili搜索工具丨PC端口，随时失效 20 三川 2周前 197 来自 电脑端 15270352105 21小时前 Win软件 ...
The Senate Labor, Health and Human Services and State and Foreign Operations Appropriations bills released by the full committee on Nov. 10 provide needed resources to address infectious diseases in the United States and abroad
Anthony Fauci, M.D., FIDSA, director of the National Institute of Allergy and Infectious Diseases, kicked off this year’s premier virtual infectious diseases conference with an overview of the public health and scientific challenges of COVID-19 in the United States. Login to this year’s program now.
Renowned leaders, policy makers and medical experts offer their thanks to NIAID Director Anthony Fauci, M.D., FIDSA, as he kicks off IDWeek 2020 and the global Chasing the Sun event.
